ABSTRACT. DNA repair proteins maintain DNA integrity; polymorphisms in genes coding for these proteins can increase susceptibility to colorectal cancer (CRC) development. We analyzed a possible association of MLH1 -93G>A and 655A>G and XRCC1 Arg194Trp and Arg399Gln polymorphisms with CRC in Mexican patients. Genomic DNA samples were obtained from peripheral blood of 108 individuals with CRC (study group) at diagnosis and 120 blood donors (control group) from Western Mexico; both groups ©FUNPEC-RP www.funpecrp.com.br Genetics and Molecular Research 11 (3): 2315-2320 (2012) R. Muñiz-Mendoza et al. 2316 were mestizos. The polymorphisms were detected by PCR-RFLP. Association was estimated by calculating the odds ratio (OR). We found that the MLH1 and XRCC1 polymorphisms were in HardyWeinberg equilibrium. The MLH1 655A>G polymorphism in the 655G allele was associated with a 2-fold increase risk for CRC (OR = 2.04 and 95% confidence interval (95%CI) = 1.12-3.69; P < 0.01), while the MLH1 -93G>A polymorphism allele was associated with a protective effect (OR = 0.60, 95%CI = 0.40-0.89; P = 0.01 in the -93A allele and OR = 0.32, 95%CI = 0.13-0.79; P = 0.01 in the AA genotype). The XRCC1 Arg194Trp and Arg399Gln polymorphisms did not show any significant associations. In conclusion, we found that MLH1 -93G>A and 655A>G polymorphisms are associated with CRC in Mexican patients.
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INTRODUCTION
Colorectal cancer (CRC) is characterized by genomic instability produced by chromosomal instability, aberrant DNA methylation, and defects in DNA repair. These mechanisms induce the accumulation of multiple tumor-specific mutations (Markowitz and Bertagnolli, 2009 (Silva et al., 2009 ). The MLH1 -93G>A (rs1800734) and 655A>G (rs1799977, I219V) polymorphisms are located in the promoter and exon 8, respectively (Allan et al., 2008; Silva et al., 2009) . The XRCC1 (X-ray repair complementing defective repair in Chinese hamster cells 1) gene is mapped at 19q13.2-13.3 and encodes a 70-kDa protein involved in the repair of DNA single-strand breaks produced by ionizing radiation and alkylating agents (Caldecott, 2003; Hung et al., 2005) . Its polymorphisms Arg194Trp (rs1799782) and Arg399Gln (rs25487) are localized in exons 6 and 10, respectively. In this study, we evaluated the association of these four polymorphisms with CRC in Mexican patients.
SUBJECTS AND METHODS

Subjects
The patient group was composed of 108 individuals diagnosed with sporadic CRC. The average age was 62 years (range 20-96) and 52% were men. The control group was constituted by 120 healthy people randomly selected from blood donors. All subjects were mestizos from Western Mexico and provided written informed consent before collection of blood samples. Five milliliters of peripheral blood with EDTA as anticoagulant was obtained from each individual.
Genomic DNA extraction and genotyping
Genomic DNA was extracted by means of the DTAB-CTAB method (Gustincich et al., 1991) . All variants were detected via PCR-RFLP assays. The primers for the MLH1 655A>G polymorphism were those described by Mei et al. (2006) , while the primers for the MLH1 -93G>A polymorphism were designed in the Oligo Primer Analysis Software v6.71 and were 5ꞌ-CGCCAGATCACCTCAGCAGA-3ꞌ (forward) and 5ꞌ-CGCCAGAAGAGCCAAGGAAA-3ꞌ (reverse). PCR conditions consisted of an initial denaturation at 94°C for 10 min followed by 35 cycles of denaturation at 94°C for 30 s, annealing at 70° (for -93G>A) or 55°C (for 655A>G) for 30 s, and extension at 72°C for 45 s, and final elongation at 72°C for 10 min. The restriction analysis for MLH1 -93G>A and 655G>A was done overnight at 37°C with PvuII and BccI, respectively. Both enzymes recognize the wild allele. The digestion products were separated on polyacrylamide gels. The XRCC1 Arg194Trp and Arg399Gln polymorphisms were detected according to Zhang et al. (2005) .
Statistical analysis
Allele and genotype frequencies were established by counting and the distribution of genotypes in both groups was compared by the chi-square test or the Fisher exact test. Hardy-Weinberg equilibrium (HWE) was evaluated by the chi-square test. Association was estimated by the odds ratio (OR) and 95% confidence interval (CI) in the SPSS v10.0 software (the wild allele was taken as reference). P < 0.05 was considered to be significant.
RESULTS
All four polymorphisms were in HWE. In CRC patients, the frequencies of the MLH1 655G allele and GG genotype were significantly higher even if the OR could not be analyzed due to absence of that genotype in the control group. As for the -93G>A polymorphism, both AA genotype and A allele were related to a significantly decreased risk. The XRCC1 Arg399Gln and Arg194Trp polymorphisms did not show any significant difference (Table 1 ). Allele and genotype frequencies of the control group were described by Meza-Espinoza et al. (2009) .
DISCUSSION
The analysis shows that MLH1 polymorphisms are associated with CRC in Mexican patients. Actually, the 655G allele appears to confer a 2-fold increased risk to develop CRC in Mexican patients, a finding similar to that observed in 140 Spanish patients with sporadic CRC (Nejda et al., 2009) . According to immunohistochemical analysis, it has been suggested that this polymorphism correlates with protein expression (Kim et al., 2004) . In vitro mismatch repair assays led to classification of the 655A>G polymorphism as MMR+ (mismatch repair activity >60%) and a normal protein function was revealed by SIFT analysis (Takahashi et al., 2007) .
Our results also show that both the AA genotype and A allele of MLH1 -93G>A polymorphism protect against CRC development. In a recent meta-analysis study, no association with CRC was observed (Pan et al., 2011) . However, Allan et al. (2008) reported that MLH1 -93A was associated with a 3-fold increased risk of CRC, negative for the MLH1 protein detectable by immunohistochemistry (OR = 3.30, 95%CI = 1.46-7.47), while Raptis et al. (2007) documented a 3-fold increased risk (P < 0.001) of CRC with MSI-H (microsatellite instability high) in a population from Ontario (OR = 3.23, 95%CI = 1.65-6.30) and an 8-fold increased risk (P < 0.001) in Newfoundland people (OR = 8.88, 95%CI = 2.33-33.9). To explain these discordant results, we propose that the MLH1 -93G>A polymorphism may be cis-acting with unidentified variants in the minimal region for transcription -defined between -302 and -76 by Arita et al. (2003) -and co-modulates MLH1 expression. Actually, these authors proved that single mutants in the MLH1 -96 to -91 region show the lowest promoter activity (approximately 13 to 17%) and that double or triple mutants (-163 to -158, -145 to -139 and -96 to -91) exhibit a moderate activity (30%) (Arita et al., 2003) . Yet, there is no conclusive evidence that the -93A allele reduces the activity of the promoter, and no nuclear factor for the MLH1 transcription has been identified (Mei et al., 2010; Perera et al., 2011) .
The non-association of the XRCC1 Arg399Gln and Arg194Trp polymorphisms with CRC in Mexican patients agrees with the results of a recent meta-analysis (Wang et al., 2010) . Such polymorphisms have also been assessed in other types of cancer. Although Wei et al. (2011) reported no association with prostate cancer, when they stratified by ethnicity, an in- creased risk for the 399Gln allele in Asian men has been reported. Chen et al. (2012) related the Trp/Trp genotype of the XRCC1 Arg194Trp polymorphism to an increased risk of gastric cancer, while Huang et al. (2009) associated dominant and recessive models for XRCC1 Arg399Gln polymorphism with breast cancer.
In conclusion, our results suggest that the MLH1 -93G>A and 655A>G polymorphisms are associated with CRC in Mexican patients.
